Channel Therapeutics Corporation announces a 10-for-one reverse stock split to increase share price and meet NYSE American listing requirements. Channel Therapeutics Corporation announced a 10-for-one ...
Channel Therapeutics Corporation is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback